{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:18:43Z","timestamp":1771373923988,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jpba.2017.01.042","type":"journal-article","created":{"date-parts":[[2017,1,29]],"date-time":"2017-01-29T02:45:25Z","timestamp":1485657925000},"page":"252-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Evaluation of in silico pharmacokinetic properties and in vitro cytotoxic activity of selected newly synthesized N-succinimide derivatives"],"prefix":"10.1016","volume":"137","author":[{"given":"Natasa P.","family":"Milosevic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"Kojic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Curcic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitar","family":"Jakimov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasa","family":"Milic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nebojsa","family":"Banjac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordana","family":"Uscumlic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Kaliszan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2017.01.042_bib0005","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpba.2017.01.042_bib0010","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: towards prediction paradise?","volume":"2","author":"van de Waterbeemd","year":"2003","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.jpba.2017.01.042_bib0015","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00216-009-2634-y","article-title":"Analytical tools for the physicochemical profiling of drug candidates to predict absorption\/distribution","volume":"394","author":"Henchoz","year":"2009","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2017.01.042_bib0020","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1359-6446(03)02649-7","article-title":"Pharmaceutical profiling in drug discovery","volume":"8","author":"Kerns","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpba.2017.01.042_bib0025","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2174\/092986706778201558","article-title":"Recent advances in computational prediction of drug absorption and permeability in drug discovery","volume":"13","author":"Hou","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpba.2017.01.042_bib0030","series-title":"Drug-like Properties: Concepts, Structure Design and Methods: From ADME to Toxicity Optimization","author":"Kerns","year":"2008"},{"key":"10.1016\/j.jpba.2017.01.042_bib0035","first-page":"79","article-title":"Lipophilicity measurements by liquid chromatography","volume":"44","author":"Gocan","year":"2006","journal-title":"Adv. Chromatogr."},{"key":"10.1016\/j.jpba.2017.01.042_bib0040","first-page":"153","article-title":"Synthesis characterization and anticancer activity of certain 3-{4-(5-mercapto-1,3,4-oxadiazole-2-yl)phenylimino}indolin-2-one derivatives, Saudi","volume":"19","author":"Gudipati","year":"2011","journal-title":"Pharm. J."},{"key":"10.1016\/j.jpba.2017.01.042_bib0045","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1007\/s00044-012-0439-6","article-title":"Synthesis, anti-inflammatory, and cytotoxicity evaluation of 9,10-dihydroanthracene-9,10-\u03b1,\u03b2-succinimide and bis-succinimide derivatives","volume":"22","author":"Arya","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jpba.2017.01.042_bib0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0753-3322(96)82631-X","article-title":"The cytotoxicity of N-Pyridinyl and N-quinolinyl substituted derivatives of phthalimide and succinimide","volume":"49","author":"Hall","year":"1995","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jpba.2017.01.042_bib0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1515\/hc-2013-0050","article-title":"Synthesis and biological activity of novel series of heterocyclic compounds containing succinimide moiety","volume":"19","author":"Kuran","year":"2013","journal-title":"Heterocycl. Commun."},{"key":"10.1016\/j.jpba.2017.01.042_bib0060","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1248\/cpb.43.2139","article-title":"Succinimide derivatives. II. Synthesis and antipsychotic activity of N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-1,2-cis-cyclohexanedicarboximide (SM-9018) and related compounds","volume":"43","author":"Ishizumi","year":"1995","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.jpba.2017.01.042_bib0065","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0014-827X(99)00033-6","article-title":"Synthesis, physicochemical and anticonvulsant properties of new N-pyridyl derivatives of 3-phenyl- and 3,3-diphenyl-succinimides","volume":"30","author":"Obniska","year":"1999","journal-title":"Farmaco"},{"key":"10.1016\/j.jpba.2017.01.042_bib0070","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1021\/jm00225a023","article-title":"Synthesis and central nervous system depressant activity of some bicyclic amides","volume":"19","author":"Aeberli","year":"1976","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2017.01.042_bib0075","first-page":"67","article-title":"Synthesis of new succinimides and sulphonated derivatives with analgesic action in mice","volume":"3","author":"Correa","year":"1997","journal-title":"Pharm. Pharmacol. Commun."},{"key":"10.1016\/j.jpba.2017.01.042_bib0080","first-page":"434","article-title":"Synthesis and pharmacological activity of N-substituted succinimide analogs","volume":"8","author":"Fhid","year":"2015","journal-title":"Int. J. PharmTech Res."},{"key":"10.1016\/j.jpba.2017.01.042_bib0085","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.farmac.2004.07.007","article-title":"Syntheses, in vitro antibacterial and cytotoxic activities of a series of 3-substituted succinimides","volume":"59","author":"Zentz","year":"2004","journal-title":"Farmaco"},{"key":"10.1016\/j.jpba.2017.01.042_bib0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0014-827X(02)01217-X","article-title":"Synthesis and antimicrobial activities of N-substituted imides","volume":"57","author":"Zentz","year":"2002","journal-title":"Farmaco"},{"key":"10.1016\/j.jpba.2017.01.042_bib0095","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2298\/HEMIND110224030B","article-title":"Succinimides: synthesis, properties and anticonvulsant activity","volume":"65","author":"Banjac","year":"2011","journal-title":"Chem. Ind."},{"key":"10.1016\/j.jpba.2017.01.042_bib0100","first-page":"4827","article-title":"Evaluation of a soluble tetrazolium\/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines","volume":"48","author":"Scudiero","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpba.2017.01.042_bib0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0021-9673(01)01278-X","article-title":"Mechanistic molecular model of liquid\u2013solid chromatography retention\u2013eluent composition relationship","volume":"965","author":"Soczewinski","year":"2002","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2017.01.042_bib0110","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1080\/10826079308021688","article-title":"Lipophilicity determination of some monoamine oxidase inhibitors: the effect of methanol and ammonium chloride","volume":"16","author":"Cserhati","year":"1993","journal-title":"J. Liq. Chromatogr."},{"key":"10.1016\/j.jpba.2017.01.042_bib0115","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/cbdv.200900115","article-title":"Lipophilicity determination of highly lipophilic compounds by liquid chromatography","volume":"6","author":"Guillot","year":"2009","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.jpba.2017.01.042_bib0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jpba.2012.09.006","article-title":"Chromatographic retention parameters in correlation analysis with in silico biological descriptors of a novel series of N-phenyl-3-methyl succinimide derivatives","volume":"72","author":"Perisic-Janjic","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.01.042_bib0125","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1021\/mp100373d","article-title":"Reversed-phase TLC and HPLC retention data in correlation studies with in silico molecular descriptors and druglikeness properties of newly synthesized anticonvulsant succinimide derivatives","volume":"8","author":"Perisic-Janjic","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jpba.2017.01.042_bib0130","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1208\/s12248-009-9144-x","article-title":"Prediction of solubility and permeability class membership: provisional BCS classification of the world\u2019s top oral drugs","volume":"11","author":"Dahan","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.jpba.2017.01.042_bib0135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0169-409X(02)00008-X","article-title":"Prediction of drug solubility from structure","volume":"54","author":"Jorgensen","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpba.2017.01.042_bib0140","series-title":"Aqueous Solubility: Methods of Estimation for Organic Compounds","author":"Yalkowsky","year":"1992"},{"key":"10.1016\/j.jpba.2017.01.042_bib0145","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jpba.2017.01.042_bib0150","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2005.01.005","article-title":"Prediction of oral drug absorption in humans by theoretical passive absorption model","volume":"293","author":"Obata","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2017.01.042_bib0155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1248\/bpb.17.327","article-title":"Drug absorption from large intestine: physicochemical factors governing drug absorption","volume":"17","author":"Kimura","year":"1994","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jpba.2017.01.042_bib0160","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2017.01.042_bib0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpba.2017.01.042_bib0170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijpharm.2006.03.043","article-title":"QSPR models for the prediction of apparent volume of distribution","volume":"319","author":"Ghafourian","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2017.01.042_bib0175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejps.2010.10.011","article-title":"Use of unbound volumes of drug distribution in pharmacokinetic calculations","volume":"42","author":"Stepensky","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2017.01.042_bib0180","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1021\/jm0200409","article-title":"Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data","volume":"45","author":"Lombardo","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2017.01.042_bib0185","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1023\/A:1016462205267","article-title":"Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models","volume":"19","author":"Lundquist","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2017.01.042_bib0190","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3109\/13550289909021285","article-title":"Blood-brain barrier biology and methodology","volume":"5","author":"Pardridge","year":"1999","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jpba.2017.01.042_bib0195","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1359-6446(03)02827-7","article-title":"In silico prediction of blood\u2013brain barrier permeation","volume":"8","author":"Clark","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpba.2017.01.042_bib0200","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1046\/j.1471-4159.1998.70051781.x","article-title":"CNS drug design based on principles of blood-brain barrier transport","volume":"70","author":"Pardridge","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpba.2017.01.042_bib0205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejps.2013.01.018","article-title":"RP TLC data in correlation studies with in silico pharmacokinetic properties of benzimidazole and benztriazole derivatives","volume":"49","author":"Milosevic","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2017.01.042_bib0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpba.2015.01.046","article-title":"Blood-brain barrier permeability mechanisms in view of quantitative structure-activity relationships (QSAR)","volume":"108","author":"Bujak","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.01.042_bib0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0378-5173(96)04712-6","article-title":"Brain\/blood distribution described by a combination of partition coefficient and molecular mass","volume":"145","author":"Kaliszan","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2017.01.042_bib0220","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.taap.2009.08.022","article-title":"Review of in silico toxicology for the pharmaceutical sciences","volume":"241","author":"Valerio","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jpba.2017.01.042_bib0225","series-title":"Material safety data sheet. Etosuximide (Zarontin) capsules","author":"Pfizer","year":"2012"},{"key":"10.1016\/j.jpba.2017.01.042_bib0230","series-title":"Material safety data sheet. Celontin (Methsuximide) Capsules","author":"Pfizer","year":"2013"},{"key":"10.1016\/j.jpba.2017.01.042_bib0235","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1528-1157.1963.tb05209.x","article-title":"Anticonvulsant activity and toxicity of phensuximide, methsuximide and ethosuximide","volume":"4","author":"Chen","year":"1963","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpba.2017.01.042_bib0240","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1081\/JLC-120003430","article-title":"Evaluation of hydrophobicity and antitumor activity of a molecule library of Mannich ketones of cycloalkanones","volume":"25","author":"Holl\u00f3sy","year":"2002","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2017.01.042_bib0245","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1021\/ci010366a","article-title":"Is there a difference between leads and drugs? A historical perspective","volume":"41","author":"Oprea","year":"2001","journal-title":"J. Chem. Inf. Comput. Sci."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851630526X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851630526X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T19:53:50Z","timestamp":1536090830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170851630526X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":49,"alternative-id":["S073170851630526X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2017.01.042","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of in silico pharmacokinetic properties and in vitro cytotoxic activity of selected newly synthesized N-succinimide derivatives","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2017.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}